1236. Staphylococcus aureus Surgical Site Infection: Epidemiology in Europe (SALT). S Mellinghoff, C Bruns, M Albertrsmeier, M Bassetti, JP Horcajada, ... Open Forum Infectious Diseases 6, 2019 | | 2019 |
1269. Cohort Profile: The Translational Platform HIV (TP-HIV), a Multicenter Cohort Project in Germany M Stecher, JC Wasmuth, E Knops, A Eis-Hübinger, J Bogner, C Spinner, ... Open Forum Infectious Diseases 6 (Supplement_2), S456-S457, 2019 | | 2019 |
1280. Geospatial Spread of HIV in the Cologne-Bonn Region, Germany: From 2001 to 2016 M Stecher, M Hoenigl, AM Eis-Huebinger, C Lehmann, G Fätkenheuer, ... Open Forum Infectious Diseases 5 (Suppl 1), S390, 2018 | | 2018 |
1283. Pretreatment HIV-1 Drug Resistance in Transmission Clusters of the Cologne-Bonn Region, Germany M Stecher, M Hoenigl, AM Eis-Huebinger, C Lehmann, G Fätkenheuer, ... Open Forum Infectious Diseases 5 (Suppl 1), S391, 2018 | | 2018 |
1568. Implementation of a Standard Diet Regimen for Neutropenic High-Risk Cancer Patients: Effects on Incidence of Infections, Foodborne Diseases, and Outcome C Jakob, AY Löhnert, M Stecher, A Engert, M Freund, A Hamprecht, ... Open Forum Infectious Diseases 5 (suppl_1), S489-S489, 2018 | | 2018 |
1598. Clinical implications of azole-resistant vs. azole-susceptible invasive aspergillosis in hematological malignancy (CLARITY) – a multicenter study D Seidel, O Cornely, M Zarrouk, P Koehler, JF Meis, J Salmanton-García, ... Open Forum Infectious Diseases 7 (Supplement_1), S795-S796, 2020 | | 2020 |
1767. Structured Treatment Interruptions in HIV-Infected Patients Receiving Antiretroviral Therapy—Implications for Future HIV Cure Trials: A Systematic Review and Meta-analysis M Stecher, AY Löhnert, F Klein, C Lehmann, C Wyen, G Fätkenheuer, ... Open Forum Infectious Diseases 5 (Suppl 1), S64, 2018 | | 2018 |
1886. External Validation of the 4C Mortality Score and the qSOFA for Different Variants of Concerns of SARS-CoV-2 Using Data of the NAPKON Cross-Sectoral Cohort Platform (SUEP) KS Appel, D Maier, SM Hopff, L Mitrov, M Stecher, M Scherer, R Geisler, ... Open Forum Infectious Diseases 9 (Supplement_2), ofac492. 1513, 2022 | | 2022 |
20 Logopädie und Intensivmedizin–519 G Michels, M Bruckner, MT Geier, S Wilke, SR Schwarzkopf, R Blomeyer, ... Repetitorium Internistische Intensivmedizin, 122, 2011 | | 2011 |
2046. FungiScope™: News on the Global Emerging Fungal Infection Registry D Seidel, P Koehler, S Mellinghoff, MJGT Vehreschild, JS García, ... Open Forum Infectious Diseases 5 (suppl_1), S597-S597, 2018 | | 2018 |
2119. Matched-Paired Analysis of Patients Treated for Invasive Mucormycosis—Standard Treatment vs. Posaconazole New Formulations (MoveOn) J Salmanton-Garcia, D Seidel, P Koehler, S Mellinghoff, H Wisplinghoff, ... Open Forum Infectious Diseases 6 (Suppl 2), S717, 2019 | | 2019 |
2187. Prediction of Patient Outcome During Febrile Neutropenia Despite Anti-infective Treatment Using Machine Learning Algorithms. C Jakob, A Classen, M Stecher, S Fuhrmann, B Franke, F Fuchs, S Walker, ... Open Forum Infectious Diseases 6, 2019 | 3 | 2019 |
2268. Clinical Implications of Azole-Resistant vs. Azole-Susceptible Invasive Aspergillosis in Hematological Malignancy (CLARITY): A Multicenter Study D Seidel, O Cornely, D Arenz, J Meis, J Vehreschild, J Salmanton-Garcia, ... Open Forum Infectious Diseases 6 (Supplement_2), S776-S776, 2019 | | 2019 |
2474. The 10 Years Scientific Contribution of the Cologne Cohort of Neutropenic Patients (CoCoNut) for Evaluating Treatment and Outcome of Healthcare-associated Infections. C Jakob, S Heimann, A Classen, M Gillis, P Thelen, U Holtick, C Scheid, ... Open Forum Infectious Diseases 6, 2019 | 2 | 2019 |
31 Systematic review of the current literature on structured treatment interruptions in HIV-infected patients receiving antiretroviral therapy–implications for future HIV cure … M Stecher, F Klein, C Lehmann, M Platten, D Gillor, G Behrens, ... | | 2016 |
32/f with planned induction therapy for newly diagnosed acute lymphoblastic leukemia: Preparation for the medical specialist examination: part 5 AY Classen, JJ Vehreschild Der Onkologe 27, 33-37, 2021 | | 2021 |
32/w mit geplanter Induktionstherapie bei neu diagnostizierter akuter lymphatischer Leukämie AY Classen, JJ Vehreschild Die Onkologie 27, 33-37, 2021 | | 2021 |
403. Prognostic Factors in 260 Adults With Invasive Scedosporiosis From Literature and FungiScope™ D Seidel, A Meißner, M Lackner, E Piepenbrock, JS García, S Mellinghoff, ... Open Forum Infectious Diseases 5 (suppl_1), S155-S155, 2018 | | 2018 |
412. Clinical and Pharmacoeconomic Evaluation of Antifungal Prophylaxis With Continuous Micafungin Compared to Posaconazole With Micafungin Bridging in Patients Undergoing … SM Heimann, MJGT Vehreschild, B Franke, O Cornely, A Hamprecht, ... Open Forum Infectious Diseases 5 (suppl_1), S157-S158, 2018 | | 2018 |
413. Intravenous and Tablet Formulation of Posaconazole in Antifungal Therapy and Prophylaxis: A Retrospective, Non-Interventional, Multicenter Analysis of Patients Treated in … DSM Heimann, O Penack, W Heinz, T Rachow, G Egerer, J Kessel, ... Open Forum Infectious Diseases 5 (Suppl 1), S158-S158, 2018 | | 2018 |